nerinetide, CAS No.500992-11-0

CAS: 500992-11-0 Cat. No.: rp174587 Fórmula: C105H188N42O30 Peso molecular: 2518.9 PubChem CID: 44568939
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
500μg
rp174587-500μg
Fabricado bajo pedido en EE. UU. · 2–4 semanas ·
—
2.399,90US$
1mg
rp174587-1mg
Fabricado bajo pedido en EE. UU. · 2–4 semanas ·
—
3.999,90US$
Enter a quantity for the sizes you want to add.
🧪
Por qué esta calidad

Moligand™ Moligand™ para flujos de trabajo cromatográficos y analíticos sensibles que requieren una interferencia mínima de la línea base.

🌡

Almacenamiento y envío

Room temperature Envío . Consulte el COA específico del lote para conocer las especificaciones exactas.

📋

Documentos de calidad

SDS, COA, ficha técnica y hoja de especificaciones disponibles para descargar. COA específico del lote accesible mediante búsqueda por número de lote.

📚

Prueba documental

Citado en 0 publicaciones revisadas por pares sobre cromatografía, síntesis orgánica y reacciones de acoplamiento cruzado.

Especificaciones

Product Name
nerinetide, CAS No.500992-11-0
Sinónimos
UNII-D45TI2TWMA | Nerinetide | Tat NR2B9c | AKOS040740169 | L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L- glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-seryl-L-alpha-a
Grado
Moligand™
Especificaciones y pureza
Moligand™
Tipo de acción
INHIBITOR
CAS
500992-11-0
Tipo de molécula
Peptide
Product Line
Productos biológicos
Almacenamiento y envío
Condiciones de almacenamiento de almacenamiento
Room temperature

Documentación

📋 Hoja de datos de seguridad (SDS)

Documento completo sobre peligros, manipulación, almacenamiento y cumplimiento normativo.

<<<<<<< HEAD Descargar SDS → ======= Descargar SDS → >>>>>>> release248-p3

✅ Certificado de análisis (COA)

Datos de calidad específicos del lote. Introduzca su número de lote para obtener el COA exacto.

Buscar COA →

📊 Ficha técnica

Resumen de referencia rápida de las especificaciones y aplicaciones del producto.

Ver ficha técnica →

🔬 Hoja de especificaciones

Atributos de calidad completos y criterios de aceptación para esta calidad.

Ver hoja de especificaciones →

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic Polymers
ClasePolypeptides
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPolypeptides
Alternative Parents Peptides  Tyrosine and derivatives  Arginine and derivatives  Phenylalanine and derivatives  Glutamic acid and derivatives  Glutamine and derivatives  Aspartic acid and derivatives  Isoleucine and derivatives  Leucine and derivatives  Valine and derivatives  N-acyl-L-alpha-amino acids  Serine and derivatives  Alpha amino acid amides  Amphetamines and derivatives  Tricarboxylic acids and derivatives  Aralkylamines  1-hydroxy-2-unsubstituted benzenoids  N-acyl amines  Amino acids  Secondary carboxylic acid amides  Primary carboxylic acid amides  Guanidines  Carboximidamides  Carboxylic acids  Carbonyl compounds  Hydrocarbon derivatives  Organic oxides  Imines  Monoalkylamines  Primary alcohols  
Molecular FrameworkAromatic homomonocyclic compounds
Substituents Polypeptide - Alpha peptide - Tyrosine or derivatives - Arginine or derivatives - Phenylalanine or derivatives - Glutamic acid or derivatives - Glutamine or derivatives - Aspartic acid or derivatives - Leucine or derivatives - Isoleucine or derivatives - N-acyl-alpha-amino acid - N-acyl-alpha amino acid or derivatives - N-acyl-l-alpha-amino acid - Valine or derivatives - Serine or derivatives - Alpha-amino acid amide - Alpha-amino acid or derivatives - N-substituted-alpha-amino acid - Amphetamine or derivatives - Tricarboxylic acid or derivatives - Phenol - Aralkylamine - 1-hydroxy-2-unsubstituted benzenoid - Monocyclic benzene moiety - Fatty acyl - Fatty amide - N-acyl-amine - Benzenoid - Secondary carboxylic acid amide - Primary carboxylic acid amide - Carboxamide group - Amino acid - Guanidine - Amino acid or derivatives - Carboximidamide - Carboxylic acid derivative - Carboxylic acid - Organooxygen compound - Organic oxygen compound - Organic nitrogen compound - Primary alcohol - Carbonyl group - Primary amine - Alcohol - Hydrocarbon derivative - Amine - Organic oxide - Organonitrogen compound - Imine - Primary aliphatic amine - Aromatic homomonocyclic compound
DescripciónThis compound belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues.
External Descriptors Not available
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Información genética
Alternate NamesUNII-D45TI2TWMA | Nerinetide | Tat NR2B9c | AKOS040740169 | L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L- glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-seryl-L-alpha-a
Reference
  • 1. Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration., The Journal of biological chemistry, Steegborn, C C and 7 more authors.
  • 2. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proceedings of the National Academy of Sciences of the United States of America, Strausberg, Robert L RL and 83 more authors.
  • 3. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)., Human genetics, Wang, Jian J and Hegele, Robert A RA.
  • 4. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase., Biochemical and biophysical research communications, Lu, Y Y, O'Dowd, B F BF, Orrego, H H and Israel, Y Y.
  • 5. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration., Clinical genetics, Wang, J J, Huff, A M AM, Spence, J D JD and Hegele, R A RA.
  • 6. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1., The Journal of biological chemistry, Yang, Guangdong G, Cao, Kun K, Wu, Lingyun L and Wang, Rui R.
  • 7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)., Genome research, Gerhard, Daniela S DS and 115 more authors.
  • 8. Towards a proteome-scale map of the human protein-protein interaction network., Nature, Rual, Jean-François JF and 37 more authors.
  • 9. The DNA sequence and biological annotation of human chromosome 1., Nature, Gregory, S G SG and 178 more authors.
  • 10. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer., International journal of cancer, Moore, Lee E LE and 14 more authors. more
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

No tested application protocols are provided for this SKU in the Product Data.

General preparation (literature guidance; not item-specific):

  • Dissolution: Start with sterile water or mildly acidified water. If necessary, pre-wet with a small volume of DMSO, then dilute with buffer/media to working concentration.
  • Working concentrations: Common ranges in cell studies span 0.1–10 μM; optimize empirically for your model and endpoint. Always include vehicle and scrambled-peptide controls.
  • Sterility: For cell-based assays, prepare under aseptic conditions and pass through a 0.22 μm filter if compatible.
  • Storage of aliquots: See Storage & Reconstitution for general practices after solution preparation.

For detailed, validated protocols (e.g., neuronal cultures, biophysical binding assays, pulldowns), consult peer-reviewed literature on nerinetide-class peptides and adapt to your laboratory’s SOPs. Ensure your sequence, salt form, and purity match those in the selected reference before reproducing conditions.

Biological Roles

Context (literature; not an item-specific claim): Nerinetide-class peptides are reported as cell-penetrating, positively charged sequences designed to mimic a PDZ-binding motif and thereby competitively modulate scaffolding proteins such as PSD-95 in neuronal signaling pathways.

  • Mechanistic rationale (literature): By presenting a C-terminal PDZ ligand, such peptides bind PDZ domains and can displace endogenous partners, altering assembly of receptor–scaffold complexes. This has been used to probe NMDA-receptor-associated signaling complexes in synaptic physiology.
  • Cell penetration: Arginine/lysine-rich sequences facilitate uptake via endocytosis and direct translocation; uptake efficiency depends on charge density, media composition, and cell type (literature).
  • Downstream readouts in research models: Calcium flux, synaptic current measurements, and biochemical markers are employed to assess pathway perturbation. Appropriate controls (scrambled or charge-matched peptides) are essential to distinguish specific PDZ targeting from charge-driven effects (literature).
  • Off-target considerations: Polybasic peptides may interact non-specifically with membranes and polyanions (e.g., heparan sulfate). Titration and time-course studies help deconvolute on-target versus off-target phenomena.

Important note: The above summarizes commonly reported research uses and biological context from the literature. This product is offered strictly for laboratory research; no claims are made regarding suitability for diagnostic or therapeutic applications. Verify sequence, purity, and salt form on the CoA to ensure alignment with your experimental design.

Buffer Applications

This product is a peptide reagent and not a buffering agent. Therefore, conventional buffer system design (e.g., phosphate, Tris, HEPES) is outside the primary scope for this item.

Practical notes (general):

  • Working solutions are typically prepared in physiological buffers (e.g., PBS, HEPES, or culture media) at pH 7.2–7.6.
  • Initial dissolution may be facilitated in water or mildly acidified water before adjustment to the desired buffer and pH (literature guidance for cationic peptides).
  • Filter sterilization (0.22 μm) can be used if sterility is required, provided the peptide is compatible with the filtration membrane.

For buffer recipes, pH ranges, and ionic strength optimization, refer to standard buffer preparation references. Choose buffers that do not interfere with your downstream assay (e.g., avoid high concentrations of multivalent anions when working with polybasic peptides).

Green Alternatives

For peptide reagents such as nerinetide, the main environmental considerations are solvent choice, buffer components, and waste minimization. The guidance below is general/literature-based and not item-specific.

Greener solvent choices:

  • Prefer water-based buffers as primary media whenever compatible with the assay. This minimizes volatile organic compound (VOC) use.
  • If a cosolvent is required, minimize DMSO content (e.g., ≤0.1–1% v/v in final assay) while maintaining solubility.

Comparison (general):

  • DMSO vs DMF: DMSO is typically safer and more acceptable from a green-chemistry standpoint than DMF while offering strong solvency for peptides.
  • Acidifiers: Use acetic acid or citrate buffers instead of TFA where feasible to reduce persistence and corrosivity in waste streams.

Operational best practices:

  • Prepare concentrated stocks to reduce container count and adsorption losses, thereby cutting plastic waste.
  • Use low-binding, recyclable polypropylene tubes where possible; avoid PTFE where not required.
  • Implement microscale assays to limit reagent consumption and downstream waste.

Energy and storage:

  • Store dry material at room temperature as per Product Data; avoid unnecessary refrigeration to reduce energy usage. After reconstitution (if applicable), consolidate freezer space and use energy-efficient units.

Disposal:

  • Aqueous peptide waste without hazardous additives may be amenable to standard aqueous waste streams per institutional policy. If using organic cosolvents or halogenated reagents, segregate accordingly. Always follow local regulations and EHS guidance.
Pharmaceutical Uses

No pharmaceutical or clinical use is claimed or supported for this catalog item; it is supplied exclusively for laboratory research use.

Formulation considerations (general, literature-based for peptide reagents used in preclinical research settings; not item-specific):

  • Vehicle selection: Aqueous buffers (e.g., isotonic saline, citrate, acetate) are common vehicles for peptides; pH and ionic strength should be optimized for stability and solubility.
  • Stabilization strategies: Inclusion of sugars or polyols (e.g., trehalose, mannitol) and adjustment of pH can improve stability during lyophilization and storage.
  • Adsorption minimization: Use low-binding plastics and pre-rinse lines to reduce peptide loss during handling and dosing in research models.
  • Sterility: For sterile applications, prepare solutions using sterile components and perform 0.22 μm filtration if compatible.

Regulatory note: No pharmacopeial monograph, excipient designation, or GMP status is specified for this item. Researchers requiring regulated-grade material should consult the CoA and contact technical support regarding available documentation or alternate grades.

Physical Properties

Item-specific physico-chemical values are not provided for this listing.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point/boiling point: Not applicable for peptides (decompose before boiling; literature generality).
  • Solubility (general literature guidance for cationic peptides; not item-specific):
    • High aqueous solubility is often observed in water or dilute acid (e.g., 0.1% TFA or 10–50 mM HCl) due to multiple basic residues.
    • Soluble in polar aprotic solvents such as DMSO; cosolvent strategies (DMSO→buffer) are commonly used to prepare working solutions.
    • Ionic strength and pH strongly influence dissolution and aggregation behavior.
  • LogP: Not applicable to peptides; they are polyionic and better described by peptide charge and hydropathy indices (literature).
  • pKa values: Governed by side chains (e.g., Arg ~12.5, Lys ~10.5, Asp/Glu ~4.0, His ~6.0 for free residues; literature values). Actual ionization depends on sequence and terminal modifications.
  • Density/refractive index/UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Practical notes (general): Wetting the powder with a small volume of solvent, brief sonication, and gradual dilution can assist dissolution. Filter sterilization (0.22 μm) may be used if compatible with intended use.

Quality and Grades
  • Catalog Grade/Purity designation: Moligand™ (as provided). This denotes inclusion in a ligand/compound library offering intended for research screening and discovery workflows. The designation describes catalog context rather than an analytical grade class (e.g., AR, HPLC). For definitive purity and analytical criteria, consult the item’s CoA/Spec Sheet.

What to expect and verify (recommendations):

  • Identity confirmation: Review peptide QC data where available (e.g., analytical HPLC trace, ESI/MALDI-MS). If sequence, termini, or counterion are critical to your work, verify these on the CoA.
  • Purity: Not specified for this item; refer to CoA/Spec Sheet. For bioassays, many users target ≥90–95% peptide purity, but required thresholds vary by application (screening vs. mechanistic biochemistry).
  • Counterion/salt form: Not specified; confirm (e.g., TFA, acetate, chloride) as it can influence solubility and assay background.
  • Residual solvents/volatile content, water, and TFA content: Not specified; consult CoA if needed for sensitive analyses (e.g., quantitative biophysics, LC-MS compatibility).

Implications for use:

  • Screening-grade peptides are suitable for exploratory biochemical assays, binding studies, and cellular work where the primary objective is ranking or mechanistic probing. For quantitative biophysical measurements or in vivo model research, additional purification, desalting, or counterion exchange may be advisable depending on project requirements.
Reaction and Applications

This catalog entry is supplied for research use as a peptide/ligand. No manufacturer application notes are provided for this SKU. The following are general, literature-based uses of nerinetide-class peptides; verify suitability for your experiment.

  • Protein–protein interaction modulation (literature): Nerinetide is widely reported as a cell-penetrating peptide used to disrupt PDZ-domain-mediated complexes involving PSD-95. Researchers employ it to interrogate scaffolding-dependent signaling and excitatory synapse biology.
  • Chemical biology probes: Utilized to acutely perturb specific adaptor interactions in neuronal systems; time-resolved addition/withdrawal enables reversible control in cell or tissue models (literature).
  • Biophysical and binding studies: Surface plasmon resonance, isothermal titration calorimetry, and pull-down assays to quantify PDZ-peptide binding energetics (sequence-dependent; literature).
  • Conjugation/labeling: The peptide can be derivatized at N-terminus/side chains for fluorescent labeling (e.g., NHS-ester dyes), biotinylation, or photo-crosslinkers to map interactomes (general peptide chemistry).

Practical tips (general):

  • Work under low-adsorption conditions (low-binding plastics, BSA-free) to minimize peptide loss.
  • Prepare fresh aliquots to reduce adsorption/oxidation; arginine-rich peptides can adhere to glass and plastics—precondition surfaces with buffer or a small amount of carrier protein if compatible with your assay.
  • Validate activity in your system with appropriate controls (scrambled peptide, vehicle) to account for charge-driven, non-specific effects.
Reaction Conditions

No chemical reaction conditions specific to this item are provided. The following are general, literature-based conditions relevant to peptide derivatization and assay preparation:

  • NHS-ester labeling: Dissolve peptide in bicarbonate buffer (50–100 mM, pH 8.3–8.5) at 0.5–2 mg/mL; add NHS-ester dye (DMSO stock) at 3–10 molar equivalents; react 30–60 min at room temperature, protected from light. Quench with Tris or glycine; purify by desalting or HPLC.
  • Maleimide coupling (if Cys present): Buffer at pH 6.5–7.0 (phosphate or HEPES); reduce disulfides with TCEP (0.5–1 mM); add maleimide reagent (1.2–2 eq); react 1–2 h at room temperature. Avoid amine-reactive buffers (e.g., Tris) during coupling.
  • Click chemistry (azide–alkyne): Install azide/alkyne handle via solid-phase synthesis or NHS-activated linkers; perform CuAAC in tBuOH/H2O with CuSO4/sodium ascorbate and TBTA ligand; typical times 30–120 min.
  • Stock solution preparation: Pre-wet with DMSO if needed, then dilute into aqueous buffer to 0.1–100 μM working concentrations depending on assay. Verify concentration by UV/AA or amino acid analysis when precision is required.

Cautions:

  • Avoid prolonged exposure to high pH (>9) to minimize deamidation/epimerization (literature).
  • Minimize exposure to strong oxidants; protect from light if conjugated to photosensitive groups.

These conditions are provided as general guidance only; optimize for your specific sequence and application.

Safety and Handling

Authoritative safety information for this item is not specified; always consult the SDS prior to use.

  • GHS classification, signal word, hazard statements, and pictograms: Not specified for this item; refer to SDS.
  • General hazards (peptide solids; literature): Low volatility; dust generation should be minimized. May cause irritation to eyes, skin, or respiratory tract on contact with powders/aerosols.
  • PPE: Laboratory coat, safety glasses, and appropriate disposable gloves (e.g., nitrile). Use a fume hood or powder hood when weighing to avoid aerosol exposure.
  • Handling: Avoid inhalation of dust and contact with skin/eyes. Use clean, dry tools. Prevent cross-contamination by using dedicated spatulas and antistatic measures.
  • First aid (overview; defer to SDS):
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical advice if irritation develops.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Incompatibilities (general): Strong oxidizers and strong acids/bases may degrade peptides. Avoid prolonged exposure to moisture and elevated temperatures.
  • Environmental precautions: Prevent release to drains where feasible; collect spills with dampened absorbent to minimize dusting.
  • Special risks: None known for peroxide formation or flammability typical of organic solvents; thermal decomposition of peptides can generate irritant fumes.

Storage per Product Data: Store at room temperature (as supplied). See Storage & Reconstitution for additional guidance after opening/reconstitution.

Solvent Selection

Nerinetide is a peptide entry; solvent selection follows general principles for basic, cell-penetrating peptides (literature guidance; not item-specific specifications).

  • Polarity: Highly polar, polycationic near neutral pH; favors aqueous media.
  • Primary solvents:
    • Water or aqueous buffers (e.g., PBS, HEPES). Adjust pH/ionic strength to mitigate aggregation.
    • Dilute acids (e.g., 0.1% TFA, 10–50 mM HCl) can improve initial dissolution of arginine/lysine-rich peptides before pH neutralization by dilution.
    • DMSO: Useful for preparing concentrated stocks (e.g., 10–50 mM) followed by dilution into buffer to desired working concentrations.
  • Cosolvent strategy: Pre-wet peptide with minimal DMSO, add water/buffer slowly with gentle vortexing/sonication. Filter-sterilize (0.22 μm) if sterility is required.
  • Avoid: High organic content (>50% acetonitrile or methanol) may precipitate peptides; strong base can cause racemization or deamidation over time.

Comparison (literature expectations):

  • DMSO vs water: DMSO enables higher initial concentrations for hydrophobic or aggregation-prone sequences; water/buffer provides physiological relevance but may limit maximum solubility.
  • Acidified water vs neutral buffer: Acidified water enhances solubility for basic peptides; neutralization post-dissolution is recommended for biological assays.

Tip: Determine concentration by UV at 214–220 nm (peptide bond) or 280 nm if aromatic residues are present (literature). Use sequence-based extinction coefficients when available.

Storage and Reconstitution
  • Storage conditions (as supplied): Room temperature (per Product Data). Protect from moisture and direct light. Keep container tightly closed. Use desiccant in secondary containment if ambient humidity is high.
  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

Reconstitution (general, literature-based guidance for peptides; not item-specific):

  • Solvent: Begin with sterile water or mildly acidified water (e.g., 0.1% TFA or 10–50 mM HCl). Alternatively, pre-wet with minimal DMSO and dilute with buffer/media.
  • Concentration: Prepare a concentrated stock compatible with your assay (e.g., 1–10 mM in DMSO or 0.1–1 mM in aqueous buffer), then dilute to working levels.
  • Mixing: Gentle vortexing and brief sonication can aid dissolution. Avoid foaming.
  • Filtration: If sterility is required and the peptide is compatible, filter through 0.22 μm PES or PVDF membranes.

Post-reconstitution storage (general):

  • Aliquot to single-use vials to avoid repeated freeze–thaw.
  • Store aqueous solutions at 2–8°C for short term (≤1 week) and at −20 to −80°C for longer term. Protect from light if labeled.
  • Thaw on ice and mix gently; discard if turbidity or precipitation persists after gentle warming.

Note: Exact stability, solubility, and concentration limits are sequence- and salt-form dependent. For definitive guidance, consult the item’s CoA/Spec Sheet.

Structure and Identity

Brief overview: Nerinetide is listed as a research peptide/ligand entry in our small-molecule and compound library category. Item-specific structural identifiers are largely not provided in the current listing.

  • Product name: nerinetide (research use only)
  • CAS: 500992-11-0
  • PubChem CID: 44568939
  • InChIKey: 429252 (as provided in Product Data)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general literature context, not item-specific specifications):

  • Nerinetide is widely reported in the literature as a cationic, cell-penetrating peptide that includes an arginine/lysine-rich domain and a short PDZ-binding motif. It is used as a protein–protein interaction (PPI) modulator probe in neuroscience research (literature).
  • 2D structural description (literature): a linear peptide comprising basic residues (e.g., Arg/Lys) that confer high net positive charge at neutral pH, plus a C-terminal PDZ ligand sequence. No stereochemical centers beyond the L-amino acids typical of peptides are implied in standard literature forms.

Important note: Specific sequence, exact counterion state, terminal modifications, salt form, and peptide length for this catalog item are not specified here; consult the CoA/Spec Sheet for definitive identity and analytical confirmation (HPLC, MS, peptide mapping).

Synthetic Utility

While nerinetide itself is typically used as a biological probe rather than a synthetic building block, peptide chemistry around this class affords several synthetic utilities (general/literature guidance):

  • Conjugation handle: The N-terminus and selected side chains (e.g., Lys ε-amine, Cys thiol if present) serve as handles for coupling to dyes, affinity tags (biotin), PEG chains, or crosslinkers using NHS esters, isothiocyanates, maleimides, or click chemistry.
  • Solid-phase modifications: If prepared on solid support, orthogonal protection schemes (Boc/Fmoc/Mtt) allow installation of noncanonical residues, staples, or lipidation to tune cell penetration and stability.
  • Fragment-based design: Scrambled or point-mutated analogs act as negative controls or SAR probes to dissect contribution of charge, hydrophobicity, and PDZ-binding residues.
  • Immobilization: Terminal functionalization enables surface coupling (e.g., NHS-activated chips for SPR) to quantify PDZ-domain binding kinetics.
  • Retro-synthetic leverage: The PDZ-binding motif can be excised and appended to alternative delivery vectors (e.g., CPP swaps) to study delivery vs. target engagement separately.

Note: Specific sequence, protective group history, counterion, and terminal modifications for this catalog item are not specified; if synthetic derivatization is planned, confirm these details on the CoA or request custom synthesis support to ensure compatibility with your chemistry.

Target Specificity

Item-specific target information is not provided in the Product Data for this SKU.

  • Target/antigen/protein: Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity/epitope/clone/isotype: Not applicable; this item is a peptide reagent, not an antibody. No target-binding specifications are provided in this listing.

If your application requires validated target engagement data (e.g., KD, IC50, or domain specificity), please consult the primary literature associated with nerinetide-class peptides and verify the exact sequence and purity on the CoA for this catalog item before use.

Preguntas frecuentes

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 500992-11-0. InChIKey XWQVQFBTSBCKLI-FKXNDIMNSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Necesita ayuda para elegir la calidad?

Nuestra guía de selección de calidades cubre la pureza, el estado del estabilizador y la idoneidad de la aplicación para todas las variantes de nuestro catálogo.

Ver la guía de calidades Moligand™ →

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.